BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.1.6//EN
X-ORIGINAL-URL:https://swecham.ch/
X-WR-CALNAME:Swedish Swiss Chamber of Commerce
X-WR-CALDESC:Networking organisation for companies and individuals
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-54ebdfbbfe6c31c39aaba9a1ee83860a@swecham.ch
DTSTART:20220323T000000Z
DTEND:20220324T000000Z
DTSTAMP:20221004T000000Z
CREATED:20221004
LAST-MODIFIED:20221011
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:PARTNER EVENT: Swiss Nordic Bio 2022
DESCRIPTION:Connecting Healthcare Innovations, Investors and Industry\nSwiss Nordic Bio at a glance\nSwiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 15 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners.\nFocus\nThe conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial corporations.\nThe conference is open for biotech and pharma companies as well as investors within the life science industry.\nAgenda\nWhat is new? \n• Swiss Nordic Bio 2022 is back to physical format\n• On the day of the conference, pre-booked 1-on-1 meetings meetings will be held face-to-face and on site\n• Together with Vator Securities we continue to make Swiss Nordic Bio a leading small & midcap healthcare conference\nWhy attend? \n• Meet the most promising healthcare companies from the Nordics & Switzerland\n• Up to 75 investors participating\n• Pitching will be possible during conference on site\n• Exclusive conference with max 200 participants admitted\n• 1 day event with +400 1-on-1 meetings\nAlready 80+ confirmed participants include\n• Investors: Earlybird, Veraison Capital, Wille Finance, Apus Capital, Hadean Ventures, IPF Partners, Eiffel Investment Group and more\n• SMEs & publicly listed companies: Scandion Oncology, Oasmia, Kancera, Sprint Bioscience, Magle Chemoswed and more\n• For the latest list see here\nWho attends?\n• Leading listed healthcare companies\n• Cutting edge private healthcare companies\n• Public equity investors focusing on SME’s\n• Venture capital and family offices\n• Pharma & medtech innovation scouts\n• For the latest list of registered participants see here\nOrganised by\n\n
URL:https://swecham.ch/events/partner-event-swiss-nordic-bio-2022/
CATEGORIES:Events
LOCATION:Flughafen Zürich, Rondellstrasse, 8058 Zürich
ATTACH;FMTTYPE=image/png:https://swecham.ch/wp-content/uploads/2022/10/Event-pic.png
END:VEVENT
END:VCALENDAR